{"DataElement":{"publicId":"3300697","version":"1","preferredName":"Disease or Disorder Ovarian Carcinoma Histology Classification Type","preferredDefinition":"A description of the ovarian carcinoma histology classification.","longName":"3128015v1.0:3411962v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3128015","version":"1","preferredName":"Disease or Disorder Histology","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"2404658v1.0:2186387v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186387","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B0-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7B1C96-9767-5C40-E040-BB89AD4372AD","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3411962","version":"1","preferredName":"Ovarian Carcinoma Histology Classification Type","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002_The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Type; a subdivision of a particular kind of thing.","longName":"3411962v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenosquamous","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"2836818","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"2836818","preferredDefinition":"A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62470ADA-0687-83FB-E040-BB89AD436FBF","latestVersionIndicator":"Yes","beginDate":"2009-02-06","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-06","modifiedBy":"ONEDATA","dateModified":"2009-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77AB-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Clear cell","valueDescription":"Clear Cell","ValueMeaning":{"publicId":"3198849","version":"1","preferredName":"Clear Cell","longName":"3198849","preferredDefinition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D999C94-A5F9-E80A-E040-BB89AD4330DB","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77B5-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Endometrioid","valueDescription":"Endometrioid Tissue Present","ValueMeaning":{"publicId":"3300683","version":"1","preferredName":"Endometrioid Tissue Present","longName":"3300683","preferredDefinition":"A microscopic finding indicating the presence in a sample of tissue that resembles endometrial tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Tissue Present","conceptCode":"C98839","definition":"A microscopic finding indicating the presence in a sample of tissue that resembles endometrial tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C5F6-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77BF-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Germ cell","valueDescription":"Germ Cell","ValueMeaning":{"publicId":"3300682","version":"1","preferredName":"Germ Cell","longName":"3300682","preferredDefinition":"A reproductive cell of the body. Germ cells are egg cells in females and sperm cells in males.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell","conceptCode":"C12597","definition":"Gametes, also known as sex cells or germ cells, are the cells that come together during fertilization or conception in organisms that reproduce sexually.  Their genetic complement consists of a single set of unpaired chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C5D1-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77C9-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Granulosa","valueDescription":"Granulosa Cell Tumor","ValueMeaning":{"publicId":"2567190","version":"1","preferredName":"Granulosa Cell Tumor","longName":"2567190","preferredDefinition":"A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulosa Cell Tumor","conceptCode":"C3070","definition":"A slow-growing sex cord-stromal tumor characterized by the presence of granulosa-like cells and Call-Exner bodies. It is almost always found in the ovary and rarely in the testis. There are two types of granulosa cell tumors: the adult and the juvenile.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D383-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77D3-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Mixed mullerian","valueDescription":"Mixed Mesodermal (Mullerian) Tumor","ValueMeaning":{"publicId":"3251392","version":"1","preferredName":"Mixed Mesodermal (Mullerian) Tumor","longName":"3251392","preferredDefinition":"A group of tumors affecting the female reproductive system, characterized by the presence of epithelial and stromal elements. It includes the following clinicopathological entities: adenofibroma, adenomyoma, Mullerian adenosarcoma, and malignant mixed mesodermal (Mullerian) tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Mesodermal (Mullerian) Tumor","conceptCode":"C3730","definition":"A group of tumors affecting the female reproductive system, characterized by the presence of epithelial and stromal elements. It includes the following clinicopathological entities: adenofibroma, adenomyoma, Mullerian adenosarcoma, and malignant mixed mesodermal (Mullerian) tumor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-A3BD-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77DD-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Mucinous","valueDescription":"Mucinous","ValueMeaning":{"publicId":"2838625","version":"1","preferredName":"Mucinous","longName":"2838625","preferredDefinition":"containing or resembling mucin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6E019-5991-F2F6-E040-BB89AD4350E9","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77E7-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3241404","version":"1","preferredName":"Other","longName":"3241404","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A5D-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77F1-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary","ValueMeaning":{"publicId":"2559695","version":"1","preferredName":"Papillary","longName":"2559695","preferredDefinition":"of or relating to or resembling papilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary","conceptCode":"C14166","definition":"Of or relating to or resembling papilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B63C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-77FB-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Serous","valueDescription":"Serous","ValueMeaning":{"publicId":"3300681","version":"1","preferredName":"Serous","longName":"3300681","preferredDefinition":"Of or producing or containing serum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous","conceptCode":"C14168","definition":"Of or producing or containing serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C570-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-7805-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2572577","version":"1","preferredName":"Unknown","longName":"2572577","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"COLBERTM","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BABEF9EC-780F-5EA4-E040-BB89AD4303C2","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3411961","version":"1","preferredName":"Ovarian Carcinoma Histology Classification Type","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002:The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4908:C16681:C25161:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BABEF9EC-7784-5EA4-E040-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2012-03-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"ONEDATA","dateModified":"2012-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BABEF9EC-7795-5EA4-E040-BB89AD4303C2","latestVersionIndicator":"Yes","beginDate":"2012-03-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-03-08","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"oc_base_dx_hist_diag_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"rcc_base_histology_diag","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the ovarian carcinom","type":"Preferred Question Text","description":"What was the ovarian carcinoma histology classification?","url":null,"context":"NHLBI"},{"name":"What was the histology of ovarian cancer?","type":"Alternate Question Text","description":"What was the histology of ovarian cancer?","url":null,"context":"NHLBI"},{"name":"What was the histology of renal carcinoma?","type":"Alternate Question Text","description":"What was the histology of renal carcinoma?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C640-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review. 2021-3-19 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}